货号:A157215
同义名:
Potassium azaorotate; Potassium otastat
Oxonic Acid Potassium Salt is an inhibitor of uricase thus inhibits uric acid metabolism. It is used to induce hyperuricemia in mice.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Potassium oxonate is a uricase inhibitor, affecting the phosphorylation of 5-FU into 5-fluorouridine-5'-monophosphate differently from allopurinol, both in cell-free extracts and intact cells. When administered orally alongside 5-FU (2 mg/kg) to Yoshida sarcoma-bearing rats, oxonic acid (10 mg/kg) specifically inhibits the conversion of 5-FU into its phosphorylated form and its incorporation into RNA in the intestines but not in tumor or bone marrow tissues[1]. Additionally, an oxonic acid diet raises plasma uric acid levels by 80-90 micromol/L, with an observed increase in blood pressure only in hyperuricemic rats subjected to a 5/6 nephrectomy (18 mmHg)[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
5.12mL 1.02mL 0.51mL |
25.62mL 5.12mL 2.56mL |
51.24mL 10.25mL 5.12mL |
CAS号 | 2207-75-2 |
分子式 | C4H2KN3O4 |
分子量 | 195.17 |
SMILES Code | O=C(C(NC1=O)=NC(N1)=O)[O-].[K+] |
MDL No. | MFCD00010565 |
别名 | Potassium azaorotate; Potassium otastat; Oxonate, potassium; Oxonic acid potassium salt; Allantoxanic Acid; Oxonic Acid (potassium salt); Oteracil potassium |
运输 | 蓝冰 |
InChI Key | IAPCTXZQXAVYNG-UHFFFAOYSA-M |
Pubchem ID | 2723920 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。
|